Molecular Characterization of Hospital- and Community-Acquired Streptococcus agalactiae Isolates among Nonpregnant Adults in Isfahan, Iran

Motallebirad, Tahereh; Fazeli, Hossein; Jalalifar, Saba; Shokri, Darioush; Moghim, Sharareh; Esfahani, Bahram Nasr

Molecular Characterization of Hospital- and Community-Acquired Streptococcus agalactiae Isolates among Nonpregnant Adults in Isfahan, Iran

Authors

¹ Department of Bacteriology and Virology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Microbiology, Faculty of Biological Sciences and Technology, Shahid Ashrafi Esfahani University, Isfahan, Iran

Abstract

Background: The increasing incidence of Group B Streptococcus (GBS) infection among nonpregnant adults has become of growing clinical and public health concern. The current study investigated the distribution of important virulence determinants and antibiotic susceptibility of GBS isolates causing community acquired (CA) and hospital acquired (HA) infections among nonpregnant adults. Materials and Methods: A total of 62 GBS, including 31 CA GBS and 31 HA GBS, were collected from a teaching hospital in Isfahan, Iran. Capsular polysaccharide genotypes (CPS), PI 1, PI 2a, PI 2b, and hypervirulent GBS adhesin (hvgA) virulence genes and antibiotic resistance profiling were determined. Results: There were 19 (30.6%) cases of underlying disease that diabetes mellitus (20.9%) was most common. The rate of multidrug resistant GBS strains was accounted for 29%. Distribution of macrolide resistant phenotypes was as follows: constitutive macrolides, lincosamides, and streptogramin B (MLSB) (15 isolates); inducible resistance to MLSB; and L phenotype (each 5 isolates) and M phenotype (1 isolate). V and Ia serotypes were the most predominant capsular type in HA GBS and CA GBS isolates, respectively. The most frequent pilus types were PI 1, PI 1+PI 2a, PI 1+PI 2b, and PI 2a. PI 1 and PI 1+PI 2a had significantly different distributions between CA and HA GBS isolates. Three CA GBS isolates (9.6%) were positive for hvgA gene that belonged to clonal complex 17/sequence type 17/CPS III/PI 1+PI 2b lineage. Conclusion: There was a significant difference in the distribution of PIs among CA GBS and HA GBS isolates in our region.

Keywords

References

1.	Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, et al. Group B Streptococcus: Global incidence and vaccine development. Nat Rev Microbiol 2006;4:932-42.
2.	Johri AK, Lata H, Yadav P, Dua M, Yang Y, Xu X, et al. Epidemiology of Group B Streptococcus in developing countries. Vaccine 2013;31 Suppl 4:D43-5.
3.	Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine 2013;31 Suppl 4:D7-12.
4.	Martins ER, Melo-Cristino J, Ramirez M, Portuguese Group for the Study of Streptococcal Infections. Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal. J Clin Microbiol 2012;50:1219-27.
5.	Collin SM, Shetty N, Guy R, Nyaga VN, Bull A, Richards MJ, et al. Group B Streptococcus in surgical site and non-invasive bacterial infections worldwide: A systematic review and meta-analysis. Int J Infect Dis 2019;83:116-29.
6.	Dutra VG, Alves VM, Olendzki AN, Dias CA, de Bastos AF, Santos GO, et al. Streptococcus agalactiae in Brazil: Serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis 2014;14:323.
7.	Martins ER, Andreu A, Melo-Cristino J, Ramirez M. Distribution of pilus islands in Streptococcus agalactiae that cause human infections: Insights into evolution and implication for vaccine development. Clin Vaccine Immunol 2013;20:313-6.
8.	Chattopadhyay D, Carey AJ, Caliot E, Webb RI, Layton JR, Wang Y, et al. Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus. Microbes Infect 2011;13:369-82.
9.	Springman AC, Lacher DW, Waymire EA, Wengert SL, Singh P, Zadoks RN, et al. Pilus distribution among lineages of group B Streptococcus: An evolutionary and clinical perspective. BMC Microbiol 2014;14:159.
10.	Pietrocola G, Arciola CR, Rindi S, Montanaro L, Speziale P. Streptococcus agalactiae non-pilus, cell wall-anchored proteins: involvement in colonization and pathogenesis and potential as vaccine candidates. Front Immunol 2018;9:602.
11.	Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007;13:236-42.
12.	Poyart C, Lamy MC, Boumaila C, Fiedler F, Trieu-Cuot P. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J Bacteriol 2001;183:6324-34.
13.	Wayne P. Performance standards for antimicrobial susceptibility testing. 26^th Informational Supplement. CLSI Document M100. Clinical Lab Standards Institute; 2016.
14.	Poyart C, Tazi A, Réglier-Poupet H, Billoët A, Tavares N, Raymond J, et al. Multiplex PCR assay for rapid and accurate capsular typing of group B streptococci. J Clin Microbiol 2007;45:1985-8.
15.	Martins ER, Melo-Cristino J, Ramirez M. Evidence for rare capsular switching in Streptococcus agalactiae. J Bacteriol 2010;192:1361-9.
16.	Teatero S, McGeer A, Low DE, Li A, Demczuk W, Martin I, et al. Characterization of invasive group B Streptococcus strains from the greater Toronto area, Canada. J Clin Microbiol 2014;52:1441-7.
17.	Farley MM, Strasbaugh LJ. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis 2001;33:556-61.
18.	Matsubara K, Yamamoto G. Invasive group B streptococcal infections in a tertiary care hospital between 1998 and 2007 in Japan. Int J Infect Dis 2009;13:679-84.
19.	Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005;41:839-47.
20.	Chaiwarith R, Jullaket W, Bunchoo M, Nuntachit N, Sirisanthana T, Supparatpinyo K. Streptococcus agalactiae in adults at Chiang Mai University Hospital: A retrospective study. BMC Infect Dis 2011;11:149.
21.	Björnsdóttir E, Martins E, Erlendsdóttir H, Haraldsson G, Melo-Cristino J, Kristinsson K, et al. Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975-2014. Clin Microbiol Infect 2016;22:379.e9-e16.
22.	Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009;49:85-92.
23.	Emaneini M, Mirsalehian A, Beigvierdi R, Fooladi AA, Asadi F, Jabalameli F, et al. High incidence of macrolide and tetracycline resistance among Streptococcus agalactiae strains isolated from clinical samples in Tehran, Iran. Maedica (Buchar) 2014;9:157-61.
24.	Mousavi SM, Nasaj M, Hosseini SM, Arabestani MR. Survey of strain distribution and antibiotic resistance pattern of group B streptococci (Streptococcus agalactiae) isolated from clinical specimens. GMS Hyg Infect Control 2016;11:Doc18.
25.	Jalalifar S, Havaei SA, Motallebirad T, Moghim S, Fazeli H, Esfahani BN. Determination of surface proteins profile, capsular genotyping, and antibiotic susceptibility patterns of Group B Streptococcus isolated from urinary tract infection of Iranian patients. BMC Res Notes 2019;12:437.
26.	Emaneini M, Jabalameli F, Mirsalehian A, Ghasemi A, Beigverdi R. Characterization of virulence factors, antimicrobial resistance pattern and clonal complexes of group B streptococci isolated from neonates. Microb Pathog 2016;99:119-22.
27.	Gizachew M, Tiruneh M, Moges F, Adefris M, Tigabu Z, Tessema B. Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: Alarming for prophylaxis. Ann Clin Microbiol Antimicrob 2019;18:3.
28.	Guo H, Fu M, Peng Q, Chen Z, Liu J, Qiu Y, et al. Antimicrobial resistance and molecular characterization of Streptococcus agalactiae from pregnant women in southern China. J Infect Dev Ctries 2019;13:802-9.
29.	Gajic I, Plainvert C, Kekic D, Dmytruk N, Mijac V, Tazi A, et al. Molecular epidemiology of invasive and non-invasive group B Streptococcus circulating in Serbia. Int J Med Microbiol 2019;309:19-25.
30.	Mohamed Sadaka S, Abdelsalam Aly H, Ahmed Meheissen M, Orief YI, Mohamed Arafa B. Group B streptococcal carriage, antimicrobial susceptibility, and virulence related genes among pregnant women in Alexandria, Egypt. Alex J Med 2018;54:69-76.
31.	Simoni S, Vincenzi C, Brenciani A, Morroni G, Bagnarelli P, Giovanetti E, et al. Molecular characterization of Italian isolates of fluoroquinolone-resistant Streptococcus agalactiae and relationships with chloramphenicol resistance. Microb Drug Resist 2018;24:225-31.
32.	Wu CJ, Lai JF, Huang IW, Hsieh LY, Wang HY, Shiau YR, et al. Multiclonal emergence of levofloxacin-resistant group B Streptococcus, Taiwan. J Antimicrob Chemother 2017;72:3263-71.
33.	Arias B, Kovacec V, Vigliarolo L, Suárez M, Tersigni C, Müller L, et al. Fluoroquinolone-resistant Streptococcus agalactiae invasive isolates recovered in Argentina. Microb Drug Resist 2019;25:739-43.
34.	Shabayek S, Spellerberg B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front Microbiol 2018;9:437.
35.	Khodaei F, Najafi M, Hasani A, Kalantar E, Sharifi E, Amini A, et al. Pilus-encoding islets in S. agalactiae and its association with antibacterial resistance and serotype distribution. Microb Pathog 2018;116:189-94.
36.	Javanmanesh F, Eshraghi N. Prevalence of positive recto-vaginal culture for Group B Streptococcus in pregnant women at 35-37 weeks of gestation. Med J Islam Repub Iran 2013;27:7-11.
37.	Sadeh M, Firouzi R, Derakhshandeh A, Bagher Khalili M, Kong F, Kudinha T. Molecular characterization of Streptococcus agalactiae isolates from pregnant and non-pregnant women at Yazd University Hospital, Iran. Jundishapur J Microbiol 2016;9:e30412.
38.	Jiang H, Chen M, Li T, Liu H, Gong Y, Li M. Molecular characterization of Streptococcus agalactiae causing community-and hospital-acquired infections in Shanghai, China. Front Microbiol 2016;7:1308.
39.	Matsubara K, Katayama K, Baba K, Nigami H, Harigaya H, Sugiyama M. Seroepidemiologic studies of serotype VIII group B Streptococcus in Japan. J Infect Dis 2002;186:855-8.
40.	Lin HC, Chen CJ, Chiang KH, Yen TY, Ho CM, Hwang KP, et al. Clonal dissemination of invasive and colonizing clonal complex 1 of serotype VI group B Streptococcus in central Taiwan. J Microbiol Immunol Infect 2016;49:902-9.
41.	Karunakaran R, Raja NS, Hafeez A, Puthucheary SD. Group B Streptococcus infection: Epidemiology, serotypes, and antimicrobial susceptibility of selected isolates in the population beyond infancy (excluding females with genital tract-and pregnancy-related isolates) at the University Malaya Medical Centre, Kuala Lumpur. Jpn J Infect Dis 2009;62:192-4.
42.	Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008;299:2056-65.
43.	Lu B, Wang D, Zhou H, Zhu F, Li D, Zhang S, et al. Distribution of pilus islands and alpha-like protein genes of group B Streptococcus colonized in pregnant women in Beijing, China. Eur J Clin Microbiol Infect Dis 2015;34:1173-9.
44.	Rosini R, Margarit I. Biofilm formation by Streptococcus agalactiae: Influence of environmental conditions and implicated virulence factors. Front Cell Infect Microbiol 2015;5:6.

Advanced Biomedical Research